In contrast, ERP29 downexpression was associated with decreased RT resistance in nasopharyngeal carcinoma cells19,20, increased CDDP efficacy in lung cancer cell line with null p5317, and better prognosis of colorectal cancer patients13. Here, ERP29 is linked to lung cancer.